My Bibliography

select

Smith R Jr, Gee KN, Kalvapudi S, Pachimatla A, Swamidoss R, Vedire Y, Washington D, Reid M, Barbi J, Yendamuri S. Sex-based differences in the lung immune microenvironment are associated with an increased risk of lung cancer in women. J Thorac Cardiovasc Surg. 2024 Jul 15;. doi: 10.1016/j.jtcvs.2024.07.017. [Epub ahead of print] PubMed PMID: 39019152; NIHMSID:NIHMS2021091.

select

Kalvapudi S, Vedire Y, Yendamuri S, Barbi J. Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges. Front Oncol. 2023;13:1286104. doi: 10.3389/fonc.2023.1286104. eCollection 2023. Review. PubMed PMID: 38144524; PubMed Central PMCID: PMC10739417.

select

Vedire Y, Seager R, Van Roey E, Gao S, Nesline M, Conroy J, Dy G, Barbi J, Pabla S, Yendamuri S. Sex-Specific Effects of Body Composition on Tumor Microenvironment in Non–Small Cell Lung Cancer. Annals of Thoracic Surgery Short Reports. 2023 September; 1(3):465-468. NIHMSID: NIHMS2002384.

select

Vedire Y, Nitsche L, Tiadjeri M, McCutcheon V, Hall J, Barbi J, Yendamuri S, Ray AD. Skeletal muscle index is associated with long term outcomes after lobectomy for non-small cell lung cancer. BMC Cancer. 2023 Aug 19;23(1):778. doi: 10.1186/s12885-023-11210-9. PubMed PMID: 37598139; PubMed Central PMCID: PMC10439565.

select

Smith R Jr, Yendamuri S, Vedire Y, Rosario S, Zollo R, Washington D, Sass S, Ivanick NM, Reid M, Barbi J. Immunoprofiling bronchoalveolar lavage cells reveals multifaceted smoking-associated immune dysfunction. ERJ Open Res. 2023 May;9(3). doi: 10.1183/23120541.00688-2022. eCollection 2023 May. PubMed PMID: 37342091; PubMed Central PMCID: PMC10277872.

select

Vedire YR, Mukherjee S, Dondapati S, Yendamuri S. Association between visceral obesity, metformin use, and recurrence risk in early-stage colorectal cancer. Sci Rep. 2023 May 24;13(1):8401. doi: 10.1038/s41598-023-34690-y. PubMed PMID: 37225730; PubMed Central PMCID: PMC10209144.

select

Vick LV, Collins CP, Khuat LT, Wang Z, Dunai C, Aguilar EG, Stoffel K, Yendamuri S, Smith R Jr, Mukherjee S, Barbi J, Canter RJ, Monjazeb AM, Murphy WJ. Aging augments obesity-induced thymic involution and peripheral T cell exhaustion altering the "obesity paradox". Front Immunol. 2022;13:1012016. doi: 10.3389/fimmu.2022.1012016. eCollection 2022. PubMed PMID: 36776393; PubMed Central PMCID: PMC9910174.

select

Mark J, Fisher DT, Kim M, Emmons T, Khan ANMN, Alqassim E, Singel K, Mistarz A, Lugade A, Zhan H, Yu H, Segal B, Lele S, Frederick P, Kozbor D, Skitzki J, Odunsi K. Carboplatin enhances lymphocyte-endothelial interactions to promote CD8(+) T cell trafficking into the ovarian tumor microenvironment. Gynecol Oncol. 2023 Jan;168:92-99. doi: 10.1016/j.ygyno.2022.11.001. Epub 2022 Nov 18. PubMed PMID: 36410228; PubMed Central PMCID: PMC11236086.

select

Rosario SR, Smith RJ Jr, Patnaik SK, Liu S, Barbi J, Yendamuri S. Altered acetyl-CoA metabolism presents a new potential immunotherapy target in the obese lung microenvironment. Cancer Metab. 2022 Oct 26;10(1):17. doi: 10.1186/s40170-022-00292-x. PubMed PMID: 36289552; PubMed Central PMCID: PMC9598035.

select

Kim M, Powers CA, Curtin LI, Fisher DT, Sexton S, Gurova KV, Skitzki JJ, Iyer RV. A Translational Hepatic Artery Infusion (HAI) Model for Hepatocellular Carcinoma in Woodchucks. J Surg Res. 2020 Jul;251:126-136. doi: 10.1016/j.jss.2020.02.002. Epub 2020 Mar 3. PubMed PMID: 32143057; PubMed Central PMCID: PMC7830851.

select

Khan ANH, Emmons TR, Wong JT, Alqassim E, Singel KL, Mark J, Smith BE, Tario JD, Eng KH, Moysich KB, Odunsi K, Abrams SI, Segal BH. Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils. Cancer Immunol Res. 2020 Jun;8(6):819-828. doi: 10.1158/2326-6066.CIR-19-0556. Epub 2020 Apr 1. PubMed PMID: 32238380; PubMed Central PMCID: PMC7269807.

select

Lynam S, Lugade AA, Odunsi K. Immunotherapy for Gynecologic Cancer: Current Applications and Future Directions. Clin Obstet Gynecol. 2020 Mar;63(1):48-63. doi: 10.1097/GRF.0000000000000513. Review. PubMed PMID: 31833846; PubMed Central PMCID: PMC7298668.

select

Singel KL, Emmons TR, Khan ANH, Mayor PC, Shen S, Wong JT, Morrell K, Eng KH, Mark J, Bankert RB, Matsuzaki J, Koya RC, Blom AM, McLeish KR, Qu J, Ram S, Moysich KB, Abrams SI, Odunsi K, Zsiros E, Segal BH. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment. JCI Insight. 2019 Mar 7;4(5). doi: 10.1172/jci.insight.122311. eCollection 2019 Mar 7. PubMed PMID: 30730851; PubMed Central PMCID: PMC6483507.

select

Mark J, Lynam S, Morrell K, Eng K, Starbuck K, Szender JB, Zsiros E, Frederick PJ. Implementation of a restrictive blood transfusion protocol in a gynecologic oncology service. Gynecol Reprod Endocrinol. 2019;3(1):1-5. doi: 10.35841/2591-7994.3.1-5. PubMed PMID: 32550597; PubMed Central PMCID: PMC7299237.

select

Mark J, Argentieri DM, Gutierrez CA, Morrell K, Eng K, Hutson AD, Mayor P, Szender JB, Starbuck K, Lynam S, Blum B, Akers S, Lele S, Paragh G, Odunsi K, de Leon-Casasola O, Frederick PJ, Zsiros E. Ultrarestrictive Opioid Prescription Protocol for Pain Management After Gynecologic and Abdominal Surgery. JAMA Netw Open. 2018 Dec 7;1(8):e185452. doi: 10.1001/jamanetworkopen.2018.5452. PubMed PMID: 30646274; PubMed Central PMCID: PMC6324564.

select

Starbuck KD, Szender JB, Duncan WD, Morrell K, Etter JL, Zsiros E, Odunsi K, Moysich K, Eng KH. Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer. PLoS One. 2018;13(11):e0206913. doi: 10.1371/journal.pone.0206913. eCollection 2018. PubMed PMID: 30418985; PubMed Central PMCID: PMC6231633.

select

Mayor P, Starbuck K, Zsiros E. Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecol Oncol. 2018 Aug;150(2):361-369. doi: 10.1016/j.ygyno.2018.05.024. Epub 2018 May 24. Review. PubMed PMID: 29803316; PubMed Central PMCID: PMC6167746.

select

Yendamuri S, Battoo A, Attwood K, Dhillon SS, Dy GK, Hennon M, Picone A, Nwogu C, Demmy T, Dexter E. Concomitant Mediastinoscopy Increases the Risk of Postoperative Pneumonia After Pulmonary Lobectomy. Ann Surg Oncol. 2018 May;25(5):1269-1276. doi: 10.1245/s10434-018-6397-6. Epub 2018 Feb 27. PubMed PMID: 29488189; PubMed Central PMCID: PMC5893391.

select

Mark J, Morrell K, Eng K, Alfiero A, Frederick PJ. Expert Review of Cervical Cytology: Does it Affect Patient Care?. J Low Genit Tract Dis. 2018 Apr;22(2):120-122. doi: 10.1097/LGT.0000000000000371. PubMed PMID: 29474233; PubMed Central PMCID: PMC5866201.

select

Kesterson JP, Szender JB, Schaefer E, Fanning J, Lele S, Frederick P. Evaluation of Association Between Gynecologic Oncology Fellowship Length and a Career in Academic Medicine. J Cancer Educ. 2018 Feb;33(1):141-146. doi: 10.1007/s13187-016-1043-0. PubMed PMID: 27125832; PubMed Central PMCID: PMC5509508.

select

Minlikeeva AN, Moysich KB, Mayor PC, Etter JL, Cannioto RA, Ness RB, Starbuck K, Edwards RP, Segal BH, Lele S, Odunsi K, Diergaarde B, Modugno F. Anthropometric characteristics and ovarian cancer risk and survival. Cancer Causes Control. 2018 Feb;29(2):201-212. doi: 10.1007/s10552-017-0997-5. Epub 2018 Jan 11. PubMed PMID: 29327114; PubMed Central PMCID: PMC5796836.

select

Szender JB, Kaur J, Clayback K, Hutton ML, Mikkelson J, Odunsi K, Dresbold C. Breadth of Genetic Testing Selected by Patients at Risk of Hereditary Breast and Ovarian Cancer. Int J Gynecol Cancer. 2018 Jan;28(1):26-33. doi: 10.1097/IGC.0000000000001122. PubMed PMID: 28930807; PubMed Central PMCID: PMC5734957.

select

Platek AJ, Cannioto RA, Etter JL, Kim J, Joseph JM, Gulati NR, Schmitt KL, Callahan E, Khachatryan E, Nagy R, Minlikeeva A, Brian Szender J, Singh AK, Danziger I, Moysich KB. The association of lifetime physical inactivity with head and neck cancer: a hospital-based case-control analysis. Eur Arch Otorhinolaryngol. 2017 Oct;274(10):3773-3780. doi: 10.1007/s00405-017-4688-3. Epub 2017 Aug 5. PubMed PMID: 28780667; PubMed Central PMCID: PMC5685923.

select

Minlikeeva AN, Freudenheim JL, Cannioto RA, Eng KH, Szender JB, Mayor P, Etter JL, Cramer DW, Diergaarde B, Doherty JA, Dörk T, Edwards R, deFazio A, Friel G, Goodman MT, Hillemanns P, Høgdall E, Jensen A, Jordan SJ, Karlan BY, Kjær SK, Klapdor R, Matsuo K, Mizuno M, Nagle CM, Odunsi K, Paddock L, Rossing MA, Schildkraut JM, Schmalfeldt B, Segal BH, Starbuck K, Terry KL, Webb PM, Zsiros E, Ness RB, Modugno F, Bandera EV, Chang-Claude J, Moysich KB. History of thyroid disease and survival of ovarian cancer patients: results from the Ovarian Cancer Association Consortium, a brief report. Br J Cancer. 2017 Sep 26;117(7):1063-1069. doi: 10.1038/bjc.2017.267. Epub 2017 Aug 17. PubMed PMID: 28817835; PubMed Central PMCID: PMC5625672.

select

Cannioto R, Etter JL, Guterman LB, Joseph JM, Gulati NR, Schmitt KL, LaMonte MJ, Nagy R, Minlikeeva A, Szender JB, Moysich KB. The association of lifetime physical inactivity with bladder and renal cancer risk: A hospital-based case-control analysis. Cancer Epidemiol. 2017 Aug;49:24-29. doi: 10.1016/j.canep.2017.04.017. Epub 2017 May 18. PubMed PMID: 28528291; PubMed Central PMCID: PMC5544555.

select

Eng KH, Morrell K, Starbuck K, Spring-Robinson C, Khan A, Cleason D, Akman L, Zsiros E, Odunsi K, Szender JB. Prognostic value of miliary versus non-miliary sub-staging in advanced ovarian cancer. Gynecol Oncol. 2017 Jul;146(1):52-57. doi: 10.1016/j.ygyno.2017.05.005. Epub 2017 May 8. PubMed PMID: 28495239; PubMed Central PMCID: PMC5592637.

select

Szender JB, Papanicolau-Sengos A, Eng KH, Miliotto AJ, Lugade AA, Gnjatic S, Matsuzaki J, Morrison CD, Odunsi K. NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer. Gynecol Oncol. 2017 Jun;145(3):420-425. doi: 10.1016/j.ygyno.2017.03.509. Epub 2017 Apr 6. PubMed PMID: 28392127; PubMed Central PMCID: PMC5497581.

select

Cresci GAM, Mayor PC, Thompson SA. Effect of butyrate and Lactobacillus GG on a butyrate receptor and transporter during Campylobacter jejuni exposure. FEMS Microbiol Lett. 2017 Mar 1;364(6). doi: 10.1093/femsle/fnx046. PubMed PMID: 28333199; PubMed Central PMCID: PMC5399911.

select

Ku AW, Muhitch JB, Powers CA, Diehl M, Kim M, Fisher DT, Sharda AP, Clements VK, O'Loughlin K, Minderman H, Messmer MN, Ma J, Skitzki JJ, Steeber DA, Walcheck B, Ostrand-Rosenberg S, Abrams SI, Evans SS. Tumor-induced MDSC act via remote control to inhibit L-selectin-dependent adaptive immunity in lymph nodes. Elife. 2016 Dec 8;5. doi: 10.7554/eLife.17375. PubMed PMID: 27929373; PubMed Central PMCID: PMC5199197.

select

Brightwell RM, Grzankowski KS, Lele S, Eng K, Arshad M, Chen H, Odunsi K. The CD47 "don't eat me signal" is highly expressed in human ovarian cancer. Gynecol Oncol. 2016 Nov;143(2):393-397. doi: 10.1016/j.ygyno.2016.08.325. Epub 2016 Aug 25. PubMed PMID: 27569584; PubMed Central PMCID: PMC5077667.

select

Grzankowski KS, Szender JB, Spring-Robinson CL, Lele SB, Odunsi KO, Frederick PJ. Evaluation of Metachronous Breast and Endometrial Cancers: Preroutine and Postroutine Adjuvant Tamoxifen Use. Int J Gynecol Cancer. 2016 Oct;26(8):1440-7. doi: 10.1097/IGC.0000000000000785. PubMed PMID: 27648713; PubMed Central PMCID: PMC5064444.

select

Mayor PC, Lele S. Photodynamic Therapy in Gynecologic Malignancies: A Review of the Roswell Park Cancer Institute Experience. Cancers (Basel). 2016 Sep 23;8(10). doi: 10.3390/cancers8100088. Review. PubMed PMID: 27669307; PubMed Central PMCID: PMC5082378.

select

Szender JB, Eng KH, Matsuzaki J, Miliotto A, Gnjatic S, Tsuji T, Odunsi K. HLA superfamily assignment is a predictor of immune response to cancer testis antigens and survival in ovarian cancer. Gynecol Oncol. 2016 Jul;142(1):158-162. doi: 10.1016/j.ygyno.2016.04.017. Epub 2016 Apr 23. PubMed PMID: 27103177; PubMed Central PMCID: PMC4917411.

select

Szender JB, Cannioto R, Gulati NR, Schmitt KL, Friel G, Minlikeeva A, Platek A, Gower EH, Nagy R, Khachatryan E, Mayor PC, Kasza KA, Lele SB, Odunsi K, Moysich KB. Impact of Physical Inactivity on Risk of Developing Cancer of the Uterine Cervix: A Case-Control Study. J Low Genit Tract Dis. 2016 Jul;20(3):230-3. doi: 10.1097/LGT.0000000000000210. PubMed PMID: 27105330; PubMed Central PMCID: PMC4920713.

select

Szender JB, Grzankowski KS, Eng KH, Odunsi K, Frederick PJ. Evaluation of satisfaction with work-life balance among U.S. Gynecologic Oncology fellows: A cross-sectional study. Gynecol Oncol Rep. 2016 Apr;16:17-20. doi: 10.1016/j.gore.2016.03.001. eCollection 2016 Apr. PubMed PMID: 27331129; PubMed Central PMCID: PMC4899516.

select

Turkoglu O, Zeb A, Graham S, Szyperski T, Szender JB, Odunsi K, Bahado-Singh R. Metabolomics of biomarker discovery in ovarian cancer: a systematic review of the current literature. Metabolomics. 2016 Apr;12(4). doi: 10.1007/s11306-016-0990-0. Epub 2016 Mar 8. PubMed PMID: 28819352; PubMed Central PMCID: PMC5557039.

select

Kolomeyevskaya NV, Szender JB, Zirpoli G, Minlikeeva A, Friel G, Cannioto RA, Brightwell RM, Grzankowski KS, Moysich KB. Oral Contraceptive Use and Reproductive Characteristics Affect Survival in Patients With Epithelial Ovarian Cancer: A Cohort Study. Int J Gynecol Cancer. 2015 Nov;25(9):1587-92. doi: 10.1097/IGC.0000000000000540. PubMed PMID: 26273932; PubMed Central PMCID: PMC4665090.

select

Eng KH, Hanlon BM, Bradley WH, Szender JB. Prognostic factors modifying the treatment-free interval in recurrent ovarian cancer. Gynecol Oncol. 2015 Nov;139(2):228-35. doi: 10.1016/j.ygyno.2015.09.011. Epub 2015 Sep 14. PubMed PMID: 26383827; PubMed Central PMCID: PMC4630152.

select

Szender JB, Lele SB. Fallopian Tube Ligation or Salpingectomy as Means for Reducing Risk of Ovarian Cancer. AMA J Ethics. 2015 Sep 1;17(9):843-8. doi: 10.1001/journalofethics.2015.17.9.stas1-1509. PubMed PMID: 26390206; PubMed Central PMCID: PMC4668199.

select

Yendamuri S. Massive Airway Hemorrhage. Thorac Surg Clin. 2015 Aug;25(3):255-60. doi: 10.1016/j.thorsurg.2015.04.009. Epub 2015 Jun 12. Review. PubMed PMID: 26210922.

select

Kolomeyevskaya N, Eng KH, Khan AN, Grzankowski KS, Singel KL, Moysich K, Segal BH. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer. Gynecol Oncol. 2015 Aug;138(2):352-7. doi: 10.1016/j.ygyno.2015.05.009. Epub 2015 May 20. PubMed PMID: 26001328; PubMed Central PMCID: PMC4522366.

select

Minlikeeva AN, Freudenheim JL, Lo-Ciganic WH, Eng KH, Friel G, Diergaarde B, Modugno F, Cannioto R, Gower E, Szender JB, Grzankowski K, Odunsi K, Ness RB, Moysich KB. Use of common analgesics is not associated with ovarian cancer survival. Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1291-4. doi: 10.1158/1055-9965.EPI-15-0508. Epub 2015 Jun 10. PubMed PMID: 26063476; PubMed Central PMCID: PMC4526413.

select

Hennon MW, Dexter EU, Huang M, Kane J, Nwogu C, Picone A, Yendamuri S, Demmy TL. Does Thoracoscopic Surgery Decrease the Morbidity of Combined Lung and Chest Wall Resection?. Ann Thorac Surg. 2015 Jun;99(6):1929-34; discussion 1934-5. doi: 10.1016/j.athoracsur.2015.02.038. Epub 2015 Apr 24. PubMed PMID: 25916876.

select

Patnaik SK, Yendamuri S, Mallick R, Dhillon SS. Reply to "MiR-205 and miR-375 microRNA Assays to Distinguish Squamous Cell Carcinoma From Adenocarcinoma in Lung Cancer Biopsies". J Thorac Oncol. 2015 Jun;10(6):e53. doi: 10.1097/JTO.0000000000000539. PubMed PMID: 26001155.

select

Khan AN, Kolomeyevskaya N, Singel KL, Grimm MJ, Moysich KB, Daudi S, Grzankowski KS, Lele S, Ylagan L, Webster GA, Abrams SI, Odunsi K, Segal BH. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer. Oncotarget. 2015 May 10;6(13):11310-26. doi: 10.18632/oncotarget.3597. PubMed PMID: 25888637; PubMed Central PMCID: PMC4484458.

select

Patnaik S, Mallick R, Kannisto E, Sharma R, Bshara W, Yendamuri S, Dhillon SS. MiR-205 and MiR-375 microRNA assays to distinguish squamous cell carcinoma from adenocarcinoma in lung cancer biopsies. J Thorac Oncol. 2015 Mar;10(3):446-53. doi: 10.1097/JTO.0000000000000423. PubMed PMID: 25695220; PubMed Central PMCID: PMC5819754.

select

Szender JB, Frederick PJ, Eng KH, Akers SN, Lele SB, Odunsi K. Evaluation of the National Surgical Quality Improvement Program Universal Surgical Risk Calculator for a gynecologic oncology service. Int J Gynecol Cancer. 2015 Mar;25(3):512-20. doi: 10.1097/IGC.0000000000000378. PubMed PMID: 25628106; PubMed Central PMCID: PMC4336209.

select

Brightwell RM, Grzankowski KS, Kaur J, Poblete S, Miller A, Lele SB, Sucheston-Campbell L, Moysich K, Odunsi KO. Higher than expected frequencies of non-ovarian cancers within a large familial ovarian cancer registry. Am J Clin Exp Obstet Gynecol. 2015;2(1):39-44. Epub 2015 Feb 15. PubMed PMID: 26605374; PubMed Central PMCID: PMC4655182.

select

Kolomeyevskaya NV, Lele SB, Miller A, Riebandt GC, Blum BL, Odunsi KO, Frederick PJ. Oxaliplatin is a safe alternative option for patients with recurrent gynecologic cancers after hypersensitivity reaction to Carboplatin. Int J Gynecol Cancer. 2015 Jan;25(1):42-8. doi: 10.1097/IGC.0000000000000307. PubMed PMID: 25356535; PubMed Central PMCID: PMC5042199.

select

Szender JB, Grzankowski KS, Eng KH, Lele SB, Odunsi K, Frederick PJ. Satisfaction with work-life balance among U.S. gynecologic oncologists, a cross-sectional study. Am J Clin Exp Obstet Gynecol. 2015;2(4):166-175. PubMed PMID: 27088113; PubMed Central PMCID: PMC4830436.